文献速递角膜与眼表疾病青光眼

既往青光眼手术眼行后弹力层内皮角膜移植术的长期结果

Long-Term Outcomes of Descemet Membrane Endothelial Keratoplasty in Eyes with Prior Glaucoma Surgery.
PubMed 文献 · Am J Ophthalmol · 2020-06-30

三组末次随访视力≥20/40比例均较术前提高(均P < .05);青光眼手术组内皮细胞丢失率(63.8% vs 47.6% vs 44.0%)和继发性移植失败率(41.6% vs 0% vs 2.4%)均更高(均P < .05),术后并发症发生率组间相似(均P > .05)。

要点

  • 既往青光眼手术眼行DMEK仍可获得良好长期视力预后。
  • 该组内皮细胞丢失率和继发性移植失败率显著高于无青光眼及药物控制组。
  • 重复DMEK的继发性移植失败率高于初次DMEK(P < .05)。

核心结论

  • 既往青光眼手术眼行DMEK可取得良好长期视力结果,但继发性移植失败率高于无此类合并症的眼。

主要发现

  • 末次随访时各组达到视力≥20/40的眼比例均高于DMEK术前(均P < .05)。
  • 青光眼手术组内皮细胞丢失率最高,为63.8%,药物控制组为47.6%,无青光眼组为44.0%(P < .05)。
  • 青光眼手术组继发性移植失败率为41.6%,药物控制组为0%,无青光眼组为2.4%(P < .05)。
  • 重复DMEK的继发性移植失败率高于初次DMEK(P < .05)。
  • 各组术后并发症发生率相似(均P > .05)。

关键数值与推荐

  • 分组:既往青光眼手术组、药物控制青光眼组、无青光眼组。
  • 主要结局:视力、内皮细胞计数、继发性移植失败率及术后并发症。

临床怎么用

  • 对既往接受青光眼手术的患者行DMEK时,应预期更高的内皮细胞丢失和继发性移植失败风险。
  • 此类患者术后需加强移植片存活监测,并重视重复DMEK失败率更高的信息。

局限性

  • 回顾性、非比较设计,样本来自单术者连续病例,随访时间范围24.2至64.4个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to evaluate the long-term outcomes of Descemet membrane endothelial keratoplasty (DMEK) in eyes that had previously undergone trabeculectomy and/or drainage device implantation. DESIGN: Retrospective, noncomparative case series. METHODS: Medical records of 251 consecutive DMEK procedures performed by 1 surgeon (S.X.D.) from 2013 to 2017 were reviewed. Patients with ≥2 years of follow-up were divided into 3 groups: eyes with prior glaucoma surgery (ST), eyes with medically treated glaucoma (MT), and eyes without glaucoma (NG). Main outcomes measured were visual acuity, endothelial cell count (ECC), rates of secondary graft failure (SGF), and postoperative complications. RESULTS: Ninety procedures (87 eyes) met inclusion criteria. The mean follow-up period of all eyes was 38.4 ± 11.2 months (range, 24.2-64.4 months). At last follow-up, the proportion of eyes reaching a vision of ≥20/40 was higher than that before the DMEK procedure in each group (all P < .05). The rate of ECC loss was the highest in the ST group compared to that in the MT and NG groups (63.8% vs 47.6% vs 44.0%, respectively; P < .05) as well as the rate of SGF (41.6% vs 0% vs 2.4%, respectively; P < .05). The rate of SGF of repeat DMEK was higher than that of primary DMEK (P < .05). The rates of postoperative complications were similar among all groups (all P > .05). CONCLUSIONS: In eyes with prior glaucoma surgery, DMEK achieved good long-term visual outcomes but experienced a higher rate of SGF than eyes without such comorbidity.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Bonnet C, Ghaffari R, Alkadi T, et al. Long-Term Outcomes of Descemet Membrane Endothelial Keratoplasty in Eyes with Prior Glaucoma Surgery. Am J Ophthalmol. 2020. PMID: 32619607. doi:10.1016/j.ajo.2020.06.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。